NAF PLUS DIN 02402017
Health Canada record
| Active ingredient(s) | SODIUM FLUORIDE F 18 7400 MBq |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09IX04 FLUDEOXYGLUCOSE (18F) |
| Original market date | 05-Apr-2013 |
| Current status date | 13-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Isologic Innovative Radiopharmaceuticals of Ontario Limited — licence 102120, currently licensed, last inspection rating I (2026-08-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM FLUORIDE F
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02462141 | OSTEOVISION | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | Solution | SODIUM FLUORIDE F 18 11.1 GBQ | Dormant |
International API supply for SODIUM FLUORIDE F
0 active FDA Drug Master Files.
Request a quote for NAF PLUS